These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 28216192

  • 1. Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity study.
    Golder V, Huq M, Franklyn K, Calderone A, Lateef A, Lau CS, Lee ALH, Navarra STV, Godfrey T, Oon S, Hoi AYB, Morand EF, Nikpour M.
    Semin Arthritis Rheum; 2017 Jun; 46(6):798-803. PubMed ID: 28216192
    [Abstract] [Full Text] [Related]

  • 2. Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort.
    Altabás-González I, Rúa-Figueroa I, Rubiño F, Mouriño Rodríguez C, Hernández-Rodríguez I, Menor Almagro R, Uriarte Isacelaya E, Tomero Muriel E, Salman-Monte TC, Carrión-Barberà I, Galindo M, Rodríguez Almaraz EM, Jiménez N, Inês L, Pego-Reigosa JM.
    Rheumatology (Oxford); 2023 Mar 01; 62(3):1162-1169. PubMed ID: 35961050
    [Abstract] [Full Text] [Related]

  • 3. Validity of systemic lupus erythematosus disease activity score (SLE-DAS) for definition of lupus low disease activity state (LLDAS).
    Abdelhady EI, Rabie M, Hassan RA.
    Clin Rheumatol; 2021 Nov 01; 40(11):4553-4558. PubMed ID: 34142298
    [Abstract] [Full Text] [Related]

  • 4. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).
    Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF, Asia-Pacific Lupus Collaboration.
    Ann Rheum Dis; 2016 Sep 01; 75(9):1615-21. PubMed ID: 26458737
    [Abstract] [Full Text] [Related]

  • 5. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
    Ramirez GA, Canti V, Moiola L, Magnoni M, Rovere-Querini P, Coletto LA, Dagna L, Manfredi AA, Bozzolo EP.
    Int J Rheum Dis; 2019 Sep 01; 22(9):1752-1761. PubMed ID: 31379114
    [Abstract] [Full Text] [Related]

  • 6. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.
    Zen M, Iaccarino L, Gatto M, Saccon F, Larosa M, Ghirardello A, Punzi L, Doria A.
    Ann Rheum Dis; 2018 Jan 01; 77(1):104-110. PubMed ID: 28970217
    [Abstract] [Full Text] [Related]

  • 7. Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab.
    Morand EF, Trasieva T, Berglind A, Illei GG, Tummala R.
    Ann Rheum Dis; 2018 May 01; 77(5):706-713. PubMed ID: 29420200
    [Abstract] [Full Text] [Related]

  • 8. Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study.
    Cho J, Shen L, Huq M, Kandane-Rathnayake R, Golder V, Louthrenoo W, Chen YH, Hamijoyo L, Luo SF, Wu YJ, Zamora L, Li Z, Sockalingam S, Katsumata Y, Harigai M, Hao Y, Zhang Z, Basnayake D, Chan M, Kikuchi J, Takeuchi T, Bae SC, Oon S, O'Neill S, Goldblatt F, Ng KPL, Law A, Tugnet N, Kumar S, Tee C, Tee M, Ohkubo N, Tanaka Y, Navarra SV, Lau CS, Hoi A, Morand EF, Nikpour M, Lateef A, Asia-Pacific Lupus Collaboration.
    Lancet Rheumatol; 2023 Oct 01; 5(10):e584-e593. PubMed ID: 38251484
    [Abstract] [Full Text] [Related]

  • 9. Remission and low disease activity in Polish patients with systemic lupus erythematosus - real-life, five-year follow-up outcomes.
    Pawlak-Buś K, Schmidt W, Leszczyński P.
    Eur Rev Med Pharmacol Sci; 2023 Feb 01; 27(3):949-959. PubMed ID: 36808341
    [Abstract] [Full Text] [Related]

  • 10. Frequency and predictors of the lupus low disease activity state in a multi-national and multi-ethnic cohort.
    Golder V, Kandane-Rathnayake R, Hoi AY, Huq M, Louthrenoo W, An Y, Li ZG, Luo SF, Sockalingam S, Lau CS, Lee AL, Mok MY, Lateef A, Franklyn K, Morton S, Navarra ST, Zamora L, Wu YJ, Hamijoyo L, Chan M, O'Neill S, Goldblatt F, Morand EF, Nikpour M, Asia-Pacific Lupus Collaboration.
    Arthritis Res Ther; 2016 Nov 09; 18(1):260. PubMed ID: 27829463
    [Abstract] [Full Text] [Related]

  • 11. Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus.
    Elefante E, Tani C, Stagnaro C, Signorini V, Parma A, Carli L, Zucchi D, Ferro F, Mosca M.
    Arthritis Res Ther; 2020 Oct 14; 22(1):241. PubMed ID: 33054823
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of achieving lupus low disease activity state and damage accrual in childhood-onset systemic lupus erythematosus.
    Na Nakorn K, Piyaphanee N, Sukharomana M, Pinpatanapong R, Charuvanij S.
    Clin Rheumatol; 2023 Jun 14; 42(6):1655-1664. PubMed ID: 36780064
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study.
    Golder V, Kandane-Rathnayake R, Huq M, Louthrenoo W, Luo SF, Wu YJ, Lateef A, Sockalingam S, Navarra SV, Zamora L, Hamijoyo L, Katsumata Y, Harigai M, Chan M, O'Neill S, Goldblatt F, Lau CS, Li ZG, Hoi A, Nikpour M, Morand EF, Asia Pacific Lupus Collaboration.
    Lancet Rheumatol; 2019 Oct 14; 1(2):e103-e110. PubMed ID: 38229337
    [Abstract] [Full Text] [Related]

  • 14. [Low disease activity and remission status of systemic lupus erythematosus in a real-world study].
    Ren L, Zhao C, Zhao Y, Zhou H, Zhang L, Wang Y, Shen L, Fan W, Li Y, Li X, Wang J, Cheng Y, Peng J, Zhao X, Shao M, Li R.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr 18; 56(2):273-278. PubMed ID: 38595244
    [Abstract] [Full Text] [Related]

  • 15. Treatment Target in Newly Diagnosed Systemic Lupus Erythematosus: The Association of Lupus Low Disease Activity State and Remission With Lower Accrual of Early Damage.
    Floris A, Piga M, Perra D, Chessa E, Congia M, Mathieu A, Cauli A.
    Arthritis Care Res (Hoboken); 2020 Dec 18; 72(12):1794-1799. PubMed ID: 31600023
    [Abstract] [Full Text] [Related]

  • 16. Frequencies and predictors of the Lupus Low Disease Activity State and remission in treatment-naïve patients with systemic lupus erythematosus.
    Gao D, Hao Y, Mu L, Xie W, Fan Y, Ji L, Zhang Z.
    Rheumatology (Oxford); 2020 Nov 01; 59(11):3400-3407. PubMed ID: 32337549
    [Abstract] [Full Text] [Related]

  • 17. How can we define low disease activity in systemic lupus erythematosus?
    Tselios K, Gladman DD, Urowitz MB.
    Semin Arthritis Rheum; 2019 Jun 01; 48(6):1035-1040. PubMed ID: 30415943
    [Abstract] [Full Text] [Related]

  • 18. LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population: data from the Almenara Lupus Cohort.
    Ugarte-Gil MF, Gamboa-Cardenas RV, Reátegui-Sokolova C, Pimentel-Quiroz VR, Medina M, Elera-Fitzcarrald C, Zevallos F, Pastor-Asurza CA, Lofland J, Zazzetti F, Karyekar CS, Alarcón GS, Perich-Campos RA.
    Lupus Sci Med; 2022 Feb 01; 9(1):. PubMed ID: 35193948
    [Abstract] [Full Text] [Related]

  • 19. Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort.
    Parodis I, Lindblom J, Barturen G, Ortega-Castro R, Cervera R, Pers JO, Genre F, Hiepe F, Gerosa M, Kovács L, De Langhe E, Piantoni S, Stummvoll G, Vasconcelos C, Vigone B, Witte T, PRECISESADS Clinical Consortium, Alarcón-Riquelme ME, Beretta L.
    Ann Rheum Dis; 2024 Jun 12; 83(7):889-900. PubMed ID: 38373843
    [Abstract] [Full Text] [Related]

  • 20. Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus.
    Piga M, Floris A, Cappellazzo G, Chessa E, Congia M, Mathieu A, Cauli A.
    Arthritis Res Ther; 2017 Nov 10; 19(1):247. PubMed ID: 29126432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.